Ad5-nCoV |
Cansino Biologics COVID-19 vaccine (against ancestral strains) |
ALT |
Alanine transaminase |
AMV |
Assisted mechanical ventilation |
BA.2 |
Omicron sub-lineage |
BA.5 |
Omicron sub-lineage |
BMI |
Body Mass Index |
BNT162b2 |
Pfizer Bio-NTech COVID-19 vaccine (against ancestral strains) |
BQ.1 |
Omicron sub-lineage |
BW.1 |
Omicron sub-lineage |
CDC |
Centers for Disease Control and Prevention, USA |
CFR |
Case fatality rate |
ChAdOx1-S/nCoV-19 AZD1222 |
University of Oxford/Astra Zeneca’s COVID-19 vaccine (against ancestral strains) |
CI |
Confidence interval |
CIGB-66/Abdala |
COVID-19 vaccine developed by Centro de Ingeniería Genética y Biotecnología del Ministerio de Salud Pública (Cuba) |
CKD |
Chronic kidney disease |
COPD |
Chronic obstructive pulmonary disease |
COVID-19 |
Coronavirus disease 2019 |
CPK |
Creatine phosphokinase |
CVD |
Cardiovascular disease |
DM |
Diabetes Mellitus |
FiO2
|
Fraction of inspired oxygen (from a gas mixture) |
Gam-COVID-Vac/Sputnik |
Gamaleya Research Institute’s COVID-19 vaccine (against ancestral strains) |
HR |
Hazard Ratio |
HT |
Systemic hypertension |
ICU |
Intensive care unit |
IMSS |
Instituto Mexicano del Seguro Social |
IS |
Immunosuppression |
LDH |
Lactate dehydrogenase |
MR |
Crude Mortality rate |
mRNA |
Messenger RNA |
Ob |
Obesity |
OECD |
Organization for the Economic Cooperation and Development |
OR |
Odd Ratio |
RR |
Relative risk |
RT-PCR |
Reverse transcription-polymerase chain reaction test |
SARS-CoV-2 |
Severe Acute Respiratory Syndrome Coronavirus 2 |
SpO2
|
Oxygen saturation |
XBB.1 |
Omicron sub-lineage |
yo |
Years old |